Expression and significance of cell immunohistochemical markers (HHF-35, CD-31, Bcl-2, P-53 and apopDETEC®) in hypertrophic cardiomyopathy

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 9-14

  Martinez Diaz F ^a   Bernal Gilar, M ^a   Gomez Zapata M ^b   Luna, A ^b  

^a Murcia Medical and Dental School   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Essential cardiomyopathy apoptosis; Hypertensive cardiomyopathy; Hypertrophic cardiomyopathy; Immunohistochemistry; Toxic cardiomyopathy

Indexed keywords

ACRIDINE ORANGE; ACTIN ANTIBODY; ALPHA ACTIN; ANTIINFECTIVE AGENT; BIOTIN; CD31 ANTIGEN; CYCLINE; KI 67 ANTIGEN; PEROXIDASE; PROTEIN BCL 2; PROTEIN P53; STREPTAVIDIN;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPSY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROSCOPY; PROTEIN EXPRESSION;

ACRIDINE ORANGE; ACTINS; ADULT; AGED; ANTIGENS, CD31; APOPTOSIS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; DNA DAMAGE; HEART VENTRICLES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642433353     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alfonso F. (1996). Miocardiopatías (VIII). Muerte súbita en la miocardiopatía hipertrófica. Rev. Esp. Cardiol. 49, 288-304.
2. Arola A., Jokinen E., Ruuskanen O., Saraste M., Pesonen E., Kuusela A-L., Tikanoja T., Paavilainen T. and Simell O. (1997). Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am. J. Epidemiol. 146, 385-393.
3. Colucci W.S. (1996). Apoptosis in the heart. N. Engl. J. Med. 335, 1224-1226.
4. Davies M.J. (1999). The investigation of sudden cardiac death. Histopathology 34, 93-98.
5. Davies M.J. and McKenna W.J. (1995). Hypertrophic cardiomyopathy. Pathology and pathogenesis. Histopathology 26, 493-500.
6. Gallo P. and D'Amati G. (2001). Cardiomyopathies. Chapter 10. In: Cardiovascular Pathology. Silver M.D., Gotlieb A.L. and Schoen F.J. (eds). Churchill Livingstone. New York. pp 285-325.
7. Granville D.J., Carthy C.M., Hunt D.W.C. and McManus B.M. (1988). Apoptosis: Molecular aspect of cell death and disease. Lab. Invest. 78, 893-913.
8. Hochster H., Wasserheit C. and Speyer J. (1995). Cardiotoxicity and cardioprotection during chemotherapy. Curr. Opin. Oncol. 7, 304-309.
9. Hsu S., Raine L. and Fanger H. (1981). Use of avidin-biotin-peroxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 29, 577-580.
10. Huber S.A. (1997). Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab. Invest. 76, 691-701.
11. Kavantzas N.G., Lazaris A.C., Agapitos E.V., Nanas J. and Davaris P.S. (2000). Histological assessment of apoptotic cell death in cardiomyopathies. Pathology 32, 176-180.
12. Kuhl U., Daun B., Seeberg B., Schultheiss H.P. and Strauer B.E. (1992). Dilated cardiomyopathy: A chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates. Herz. 17, 97-106.
13. Kuhl U., Noutsias M. and Schultheiss H.P. (1995). Immunohistochemistry in dilated cardiomyopathy. Eur. Heart. J. 16, 100-106.
14. Lachica E., Villanueva E. and Luna A. (1988). Comparison of different techniques for the post-mortem diagnosis of myocardial infartion. Forensic. Sci. Int. 38, 21-26.
15. Lasbellaoui F., Faure C., Magnier S., Guillonneau M., Cezard J.P., Navarro J. and Jacqz-Aigrain E. (1997). Myocardiopathie hypertrophique compliquant une corticotherapie prolongee pour rectocolite hemorragique. Arch. Pediatr. 4, 48-51.
16. Litovsky S.H. and Rose A.G. (1988). Clinicopathologic heterogeneity in hypertrophic cardiomyopathy, with regard to age, asymmetric septal hypertrophy, and concentric hypertrophy beyond the pediatric age group. Arch. Pathol. Lab. Med. 122, 434-441.
17. Liu Y.U., Gigola E., Cheng W., Kajstura J., Olivetti G., Hintze T.H. and Anversa P. (1995). Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab. Invest. 73, 771-787.
18. Matturri L., Biondo B., Colombo B., Lavezzi A.M. and Rossi L. (1997). Significance of the DNA synthesis in hypertrophic cardiomyopathies. Basic. Res. Cardiol. 92, 85-89.
19. Moolman J.C., Corfield V.A., Posen B., Ngumbela K., Seidman Ch., Brink P.A. and Watkins H. (1997). Sudden death due to troponin mutations. J. Am. Coll. Cardiol. 29, 549-555.
20. Narula J., Haider N., Virmani R., Disalvo T.G., Kolodgie F.D., Hajjar R.J., Schmidt U., Semigran M.J., William Dec G. and Khaw B-A. (1996). Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335, 1182-1189.
21. Pai V.B. and Nahata M.C. (2000). Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention. Drug. Saf. 22, 263-302.
22. Schoen F.J. (1999). El corazón. In: Patología Estructural y Funcional. Cotran R.S., Kumar V. and Collins T. (eds). McGraw-Hill-Interamericana. México. pp 571-630.
23. Steinberger J., Lucas R.V., Edwards J.E. and Titus J.L. (1996). Causes of sudden unexpected cardiac death in the first two decades of life. Am. J. Cardiol. 77, 992-995.
24. Tanaka T., Sohmiya K. and Kawamura K. (1997). Is CD 36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?. J. Moll. Cell. Cardiol. 29, 121-127.
25. Teare D. (1958). Asymmetrical hypertrophy of the heart in young adults. Br. Heart. J. 20, 1-8.
26. Tomita Y., Kusama Y., Seino Y., Munakata K., Kishida H. and Hayakama H. (1997). Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy. Am. Heart J. 134, 779-786.
27. Valente M.L., Calabrese F., Thiene G., Angelini A., Basso C., Nava A. and Rossi L. (1998). In vivo evidence of apoptosis in Arrhythmogenic right ventricular cardiomyopathy. Am. J. Pathol. 152, 479-484.
28. Vikstrom K.L., Bohlmeyer T., Factor S.M. and Leinwand L.A. (1998). Hypertrophy, pathology and molecular markers of cardiac pathogenesis. Circ. Res. 82, 773-778.
29. Virmani R., Burke A.P. and Farb A. (2001). Sudden cardiac death. Cardiovasc. Pathol. 10, 211-218.
30. Walsh T.K. and Vacek J.L. (1986). Ethanol and heart disease: An underestimated contributing factor. Postgrad. Med. 79, 60-75.
31. Wang L., Ma W., Markovich R., Chen J-W. and Wang P.H. (1998). Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 83, 516-522.
32. Zhang J., Clark J.R., Herman E.H. and Ferrans V.J. (1996). Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J. Moll. Cell. Cardiol. 28, 1931-1943.